Full-Time

Director – Business Operations

Confirmed live in the last 24 hours

Revolution Medicines

Revolution Medicines

501-1,000 employees

Develops targeted therapies for RAS-driven cancers

Biotechnology
Healthcare

Compensation Overview

$204k - $255kAnnually

Expert

San Carlos, CA, USA

This is a hybrid position, requiring some in-office days.

Category
Project Management
Strategy Development
Business Development
Business & Strategy
Required Skills
Visio
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

You match the following Revolution Medicines's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree in relevant discipline
  • >10 years of experience in a relevant pharmaceutical industry operations role with a thorough understanding of commercial and business operations
  • Know what it takes for a pre-commercial pharmaceutical organization to thrive and grow
  • Possess a sense of curiosity, passion, and a willingness to dive in to get the job done quickly and effectively
  • Must be a self-starter and able to function independently in a fluid environment under tight timelines
  • Innovative, proactive, and collaborative team-player with high energy to keep pace with our growing and evolving company environment
  • A proven history of being able to influence and rally diverse stakeholders using both qualitative and quantitative insights
  • Ability to not only dive into details to drive execution but also zoom out to contextualize specific recommendations/initiatives within the broader company strategy
  • Ability to multi-task by prioritizing work and coordinating required support across various functions to achieve project goals and objectives
  • Experience implementing and scaling initiatives across diverse teams
  • Demonstrated people and vendor management skills
  • Working knowledge of G&A applications supporting procurement, legal contracts, etc., QA and Regulatory document systems
  • Advanced capability with MS Office software (Excel, PowerPoint, Word, and Project), collaboration platforms (Smartsheet, Teams), workflow applications and visualization tools (Visio, LucidCharts, mindmaps)
Responsibilities
  • Refine and execute RevMed’s organizational readiness plan for commercialization within our corporate functions
  • Proactively identify interdependencies across G&A, Commercial and Development that will influence launch strategies and execution
  • Develops strong, collaborative relationships with functional leaders across the organization to align on strategy, prioritize activities, resolve issues and communicate progress
  • Champion innovation and change by challenging the status quo and helping leaders scale their organizations
  • Manage projects involving strategy refinement, policy and process definition, enablement, and implementation
  • Leverage knowledge of relevant enterprise solutions to stream-line processes while having the capacity to support growth
  • Design and execute change management plans to ensure rapid and comprehensive uptake of new solutions and systems
  • Manages consultants and cross-functional working teams to design and execute the organizational readiness plan
  • Be a role model for RevMed Core values
Desired Qualifications
  • MBA, MSc. or Ph.D. in Life Sciences a plus
  • Experience in Oncology therapeutic area

Revolution Medicines develops treatments specifically for cancers caused by RAS gene mutations, which are common in difficult-to-treat cancers like pancreatic, colorectal, and lung cancers. Their main product line includes RASON Inhibitors, designed to target and inhibit RAS proteins that contribute to cancer growth. The company uses a Tri Complex Inhibitor platform to create these specialized therapies. Unlike many competitors, Revolution Medicines focuses solely on RAS-driven cancers, allowing them to carve out a niche in the oncology market. Their goal is to transform cancer treatment by providing effective targeted therapies for patients suffering from these challenging conditions.

Company Stage

IPO

Total Funding

$219.8M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

-2%

1 year growth

-2%

2 year growth

7%
Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of EQRx adds over $1 billion in capital for R&D.
  • FDA fast-tracking supports their RAS-targeted therapy pipeline.
  • Growing interest in targeted cancer therapies boosts investment opportunities.

What critics are saying

  • EQRx acquisition may pose integration challenges and cultural clashes.
  • $600M public stock offering could lead to shareholder dilution.
  • Focus on RAS-addicted cancers limits market scope and increases competition risk.

What makes Revolution Medicines unique

  • Revolution Medicines reconfigures natural substances into best-in-class cancer therapies.
  • Their Tri Complex Inhibitor platform targets RAS proteins driving cancer growth.
  • Exclusive license with University of Illinois enhances their unique synthesis technology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity